CANCER FACT SHEETS: LIVER CANCER
|
|
|
- Gary Lester
- 5 years ago
- Views:
Transcription
1 CANCER FACT SHEETS: LIVER CANCER Estimated age-standardised rates (World) in the world (per ) At a glance China WHO Western Pacific Region Less developed regions World WHO African Region United States of America WHO Eastern Mediterranean Region More developed regions IARC Member State (24 countries) European Union (EU-28) Males Females Incidence Mortality Liver cancer is the fifth most common cancer in men and the ninth most common cancer in women, and it is largely a problem of the less developed regions. In 2012, worldwide, there are estimated to have been new cases, with 83% of these cases occurring in less developed regions (50% in China alone). Of this total number of incident cases, occurred in men (accounting for 7.5% of all incident cancer cases in men) and occurred in women (accounting for 3.4% of all incident cancer cases in women). In men, the highest estimated 2012 age-standardized incidence rates (per population) are in eastern and south-eastern Asia (with 31.9 and 22.2 cases, respectively). Intermediate rates are estimated in southern Europe (9.5 cases) and North America (9.3 cases), and the lowest estimated rates are in northern Europe (4.6 cases) and south-central Asia (3.7 cases). In women, the incidence is generally much lower, with the highest estimated 2012 rates in eastern Asia and western Africa (10.2 and 8.1 cases, respectively) and the lowest in northern Europe (1.9 cases) and Micronesia (1.6 cases). WHO Region of the Americas WHO South-East Asia Region WHO European Region India Liver cancer is the second most common cause of death from cancer worldwide, estimated to have been responsible for nearly deaths in 2012 (9.1% of all cancer deaths that year). The prognosis for liver cancer is very poor (with an overall ratio of mortality to incidence of 0.95), so the geographical patterns in incidence and mortality are very similar.
2 Estimated incidence, mortality and prevalence (5 years) worlwide in 2012 Estimated numbers Males Females Both sexes Cases Deaths 5-year-prev Cases Deaths 5-year-prev Cases Deaths 5-year-prev World More developed regions Less developed regions WHO African Region WHO Region of the Americas WHO Eastern Mediterranean Region WHO European Region WHO South-East Asia Region WHO Western Pacific Region IARC Member State (24 countries) United States of America China India European Union (EU-28)
3 Estimated age-standardized rates (World) of incidence cases, males, liver cancer, worldwide in < 1.2 No data Not applicable All rights reserved. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization / International Agency for Research on Cancer concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate borderlines for which there may not yet be full agreement. Data source: GLOBOCAN 2012 Graph production: IARC ( World Health Organization International Agency for Research on Cancer 2016
4 Estimated age-standardized rates (World) of incidence cases, males, liver cancer, worldwide in 2012 NORDCAN ( ECO (eco.iarc.fr) England: CI5.iarc.fr CI5.iarc.fr Australia : New Zealand : wwww.health.govt.nz USA: seer.cancer.gov
5 Estimated age-standardized rates (World) of deaths, males, liver cancer, worldwide in < 1.1 No data Not applicable All rights reserved. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization / International Agency for Research on Cancer concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate borderlines for which there may not yet be full agreement. Data source: GLOBOCAN 2012 Graph production: IARC ( World Health Organization International Agency for Research on Cancer 2016
6 Estimated age-standardized rates (World) of incidence cases, females, liver cancer, worldwide in < 0.00 No data Not applicable All rights reserved. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization / International Agency for Research on Cancer concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate borderlines for which there may not yet be full agreement. Data source: GLOBOCAN 2012 Graph production: IARC ( World Health Organization International Agency for Research on Cancer 2016
7 Estimated age-standardized rates (World) of incidence cases, females, liver cancer, worldwide in 2012 NORDCAN ( ECO (eco.iarc.fr) England: CI5.iarc.fr CI5.iarc.fr Australia : New Zealand : wwww.health.govt.nz USA: seer.cancer.gov
8 Estimated age-standardized rates (World) of deaths, females, liver cancer, worldwide in < 0.00 No data Not applicable All rights reserved. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization / International Agency for Research on Cancer concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate borderlines for which there may not yet be full agreement. Data source: GLOBOCAN 2012 Graph production: IARC ( World Health Organization International Agency for Research on Cancer 2016
CANCER FACT SHEETS: BREAST CANCER
CANCER FACT SHEETS: BREAST CANCER Estimated age-standardised rates (World) in the world (per 100 000) At a glance WHO South-East Asia Region More developed regions WHO African Region WHO Region of the
CANCER FACT SHEETS: STOMACH CANCER
CANCER FACT SHEETS: STOMACH CANCER Estimated age-standardised rates (World) in the world (per 100 000) At a glance WHO Western Pacific Region China Less developed regions World More developed regions IARC
CANCER FACT SHEETS: ALL CANCERS EXCLUDING NON-MELANOMA SKIN CANCER
CANCER FACT SHEETS: ALL CANCERS EXCLUDING NON-MELANOMA SKIN CANCER Estimated age-standardised rates (World) in the world (per 100 000) At a glance United States of America European Union (EU-28) More developed
The epidemiology of tuberculosis
The epidemiology of tuberculosis Tuberculosis Workshop Shanghai, 12-22 May 28 Philippe Glaziou World Health Organization Outline Epidemiology refresher Estimates of tuberculosis disease burden Notifications
3.1 PHASE 2 OF THE GLOBAL PROJECT
RESULTS CHAPTER 3 3.1 PHASE 2 OF THE GLOBAL PROJECT (1996 1999) This new report of the Global Project provides data on anti-tuberculosis drug resistance from 58 geographical settings. Of these, 28 provided
Table 1. Measles case classification and incidence by country and area, WHO Western Pacific Region,
Volume 7 Issue 5 May 2013 ISSN 1814 3601 Table 1. case classification and by country and area, WHO Western Pacific Region, 2008 2013 1 confirmed 2 2 009 per confirmed 2 2 010 2 011 2 012 2013 1 Confirmed
511,000 (57% new cases) ~50,000 ~30,000
Latest global TB estimates - 2007 (Updated Mar 2009) All forms of TB Greatest number of cases in Asia; greatest rates per capita in Africa Multidrug-resistant TB (MDR-TB) Estimated number of cases 9.27
Figure 1. Incidence rate of total (confirmed and compatible) measles cases with rash onset 1 31 December 2018, WHO Western Pacific Region
Volume 13 Issue 1 uary 2019 ISSN 1814 3601 Figure 1. Incidence rate of total ( and compatible) measles cases with rash onset 1 31 ember, WHO Western Pacific Region Legend: No cases
2010 global TB trends, goals How DOTS happens at country level - an exercise New strategies to address impediments Local challenges
Outline of what it will take Tuberculosis Elimination 25: Global and Local Challenges Anne Fanning, MD November 9, 211 21 global TB trends, goals How DOTS happens at country level - an exercise New strategies
What can be done against XDR-TB?
What can be done against XDR-TB? Dr Matteo Zignol Stop TB Dep. World Health Organization Geneva 16 th Swiss Symposium on tuberculosis Münchenwiler, 22 March 2007 XDR-TB Extensive Drug Resistance XDR =
Figure 1. Distribution of confirmed measles cases with rash onset 1 31 July 2014, WHO Western Pacific Region
Volume 8 Issue 8 ust 2014 ISSN 1814 3601 Figure 1. Distribution of confirmed measles cases with rash onset 1 31 y 2014, WHO Western Pacific Region 1 dot = 1 case Legend: No confirmed case With confirmed
Figure 1. Distribution of confirmed measles cases with rash onset 1 31 August 2014, WHO Western Pacific Region
Volume 8 Issue 9 tember 2014 ISSN 1814 3601 Figure 1. Distribution of confirmed measles cases with rash onset 1 31 ust 2014, WHO Western Pacific Region 1 dot = 1 case Legend: No confirmed case With confirmed
MAPS ON GLOBAL TOBACCO CONTROL POLICY DATA
APPENDIX XII: MAPS ON GLOBAL TOBACCO CONTROL POLICY DATA Appendix XII provides global overview maps on monitoring tobacco prevalence, smoke-free environments, treatment of tobacco dependence, health warnings
Figure 1. Distribution of confirmed measles cases with rash onset 1 30 September 2014, WHO Western Pacific Region
Volume 8 Issue 10 ober 2014 ISSN 1814 3601 Figure 1. Distribution of confirmed measles cases with rash onset 1 30 tember 2014, WHO Western Pacific Region 1 dot = 1 case Legend: No confirmed case With confirmed
Cotton Trade 02/03 03/04 04/05 05/06 06/07 07/08 08/09 09/10 10/11 11/12 12/13
Cotton Trade Net Exporters Africa Argentina Australia India Other Former Soviet Union Other Latin America Other Middle East Pakistan Turkey United States Uzbekistan Total Net Exports 5.01 5.62 5.62 5.66
Epidemiology of Hepatitis B in sub-saharan Africa. 7 February 2018 Yusuke Shimakawa, MD, PhD Institut Pasteur
Epidemiology of Hepatitis B in sub-saharan Africa 7 February 2018 Yusuke Shimakawa, MD, PhD Institut Pasteur From the Big Three to the Big Four 1600000 Number of deaths/year 1400000 HAV + HEV 1200000 1000000
Legend: No confirmed case With confirmed case No case based data
Volume 10 Issue 4 il 2016 ISSN 1814 3601 Figure 1. Distribution of confirmed measles cases with rash onset 1 31 ch 2016, WHO Western Pacific Region Legend: No confirmed case With confirmed case No case
Figure 1. Incidence rate of total (confirmed and compatible) measles cases with rash onset 1 31 March 2018, WHO Western Pacific Region
Volume 12 Issue 4 April ISSN 1814 3601 Figure 1. Incidence rate of total ( compatible) measles cases with rash onset 1 31 ch, WHO Western Pacific Region Legend: No cases
Figure 1. Incidence rate of total (confirmed and compatible) measles cases with rash onset 1 31 December 2017, WHO Western Pacific Region
Volume 12 Issue 1 January 2018 ISSN 1814 3601 Figure 1. Incidence rate of total ( compatible) measles with rash onset 1 31 ember, WHO Western Pacific Region Legend: Pacific isl countries areas No
Figure 1. Confirmed measles cases, WHO Western Pacific Region, 1 31 March 2014
Volume 8 Issue 4 il 2014 ISSN 1814 3601 Figure 1. Confirmed measles cases, WHO Western Pacific Region, 1 31 ch 2014 1 dot = 1 case Confirmed cases Australia 33 Brunei Darussalam 0 Cambodia 0 China 7675
TUBERCULOSIS CONTROL IN THE WHO WESTERN PACIFIC REGION In the WHO Western Pacific Region 2002 Report
TUBERCULOSIS CONTROL IN THE WHO WESTERN PACIFIC REGION 2000 Tuberculosis Control In the WHO Western Pacific Region 2002 Report World Health Organization Office for the Western Pacific Region iii TUBERCULOSIS
Figure 1. Confirmed measles cases, WHO Western Pacific Region, 1 30 January 2014
Volume 8 Issue 2 ruary 2014 ISSN 1814 3601 Figure 1. Confirmed measles cases, WHO Western Pacific Region, 1 30 uary 2014 1 dot = 1 case Confirmed cases Australia 70 Brunei Darussalam 0 Cambodia 0 China
Measles cases MCV1 coverage MCV2 coverage
Volume 7 Issue 9 tember 2013 ISSN 1814 3601 30 000 Figure 1. cases by month of onset, WHO Western Pacific Region, 2008 2013 1 Number of cases 25 000 20 000 15 000 10 000 5 000 0 2008 2009 2010 2011 2012
Measles and Rubella Global Update SAGE 19 October 2017
Measles and Rubella Global Update SAGE 19 October 2017 Alya Dabbagh WHO HQ, IVB/EPI Global update Overview Regional progress and challenges M&RI Midterm Review updates Economics of measles and rubella
Legend: No confirmed case With confirmed case No case based data
Volume 11 Issue 1 uary 2017 ISSN 1814 3601 Figure 1. Distribution of confirmed measles cases with rash onset 1 31 ember, WHO Western Pacific Region Legend: No confirmed case With confirmed case No case
C R E A E. Consortium to Respond Effectively to the AIDS-TB Epidemic. An International Research Partnership
C R E A E Consortium to Respond Effectively to the AIDS-TB Epidemic An International Research Partnership Supported by the Bill and Melinda Gates Foundation http://www.tbhiv-create.org Overview What is
Legend: No confirmed case With confirmed case No case based data
Volume 11 Issue 3 ch ISSN 1814 3601 Figure 1. Distribution of measles cases with rash onset 1 28 ruary, WHO Western Pacific Region Legend: No case With case No case based data Dots are placed at random
Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN
UNAIDS DATA TABLES 2011 Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN 978-92-9173-945-5 UNAIDS / JC2225E The designations employed and the presentation of
宮村参考人提出資料 資料 2-2
宮村参考人提出資料 資料 - Highlights of New Wild Poliovirus and cvdpv Positives Reported Globally this Week WPV cvdpv AFP other AFP other Afghanistan 5 Pakistan 3 Nigeria Location: state/province/governorate Kunar
Hepatitis B vaccination worldwide: Lessons learnt and the way forward
Hepatitis B vaccination worldwide: Lessons learnt and the way forward VHPB Russia meeting Oct 2018 Pierre Van Damme MD, PhD History Hepatitis B vaccines have been available since early 1980 s First recommended
East Carolina University Continuing Education Courses for Sustainability Symposium
East Carolina University Continuing Education Courses for 2016-17 2017 Sustainability Symposium Sustainability has emerged as a primary concern for many sectors, including academic institutions and industries
Figure 1. Distribution of confirmed measles cases with rash onset 1 31 December 2014, WHO Western Pacific Region
Volume 9 Issue 1 uary 2015 ISSN 1814 3601 Figure 1. Distribution of confirmed measles cases with rash onset 1 31 ember 2014, WHO Western Pacific Region Legend: No confirmed case With confirmed case No
Name of the presenter
Progress in tuberculosis care: setting the scene for Central Asia Name of the presenter Gombogaram Tsogt, Shalva Gamtsemlidze Quality Health Care Project Global TB estimates All forms of TB greatest number
Legend: No confirmed case With confirmed case No case based data
Volume 11 Issue 10 ober ISSN 1814 3601 Figure 1. Distribution of measles with rash onset 1 30 tember, WHO Western Pacific Region Legend: No case With case No case based data Dots are placed at rom within
A Review of the Sutezolid (PNU ) Patent Landscape
2014 A Review of the Sutezolid (PNU-100480) Patent Landscape A scoping report JANUARY 2014 A Review of the Sutezolid (PNU-100480) Patent Landscape UNITAID Secretariat World Health Organization Avenue Appia
Polio: A Global Update. DCVMN-- Seoul, Korea Simona Zipursky, WHO/HQ/POL September
Polio: A Global Update DCVMN-- Seoul, Korea Simona Zipursky, WHO/HQ/POL September 27. 2017 1 Polio Eradication and Endgame Strategy 1. Poliovirus detection & interruption 2. OPV2 withdrawal, IPV introduction,
Legend: No confirmed case With confirmed case** No case based data
Volume 11 Issue 9 September ISSN 1814 3601 Figure 1. Distribution of measles with rash onset 1 31 ust, WHO Western Pacific Region Legend: No case With case** No case based data Dots are placed at rom within
Volume 10 Cervix Cancer Screening
IARC Handbooks of Cancer Prevention Volume 10 Cervix Cancer Screening International Agency For Research On Cancer The International Agency for Research on Cancer (IARC) was established in 1965 by the World
The Gates Challenge. Bill Gates Commencement Address Harvard University Class of 2007
History & Future of the Expanded Programme on Immunization Supplier Meeting, Copenhagen, 3-4 April 2008 Dr Osman David Mansoor Senior Adviser EPI (New Vaccines) UNICEF New York The Gates Challenge If we
WHO Rotavirus Vaccine Update Dr. Fatima Serhan WHO/FWC/IVB/EPI
WHO Rotavirus Vaccine Update 2012 Dr. Fatima Serhan WHO/FWC/IVB/EPI WHO estimates that 453 000 child deaths occurred during 2008 due to rotavirus infection 41057 32653 39144 98621 82% of these deaths occurred
EBOLA SITUATION REPORT
EBOLA SITUATION REPORT 11 FEBRUARY 2015 CASES/ DEATHS (data up to 8 February 2015) Guinea Liberia Sierra Leone Mali Nigeria Senegal Spain United Kingdom United States of America Total 8 6 20 8 1 0 1 0
Intercountry meeting of national malaria programme managers from countries of HANMAT and PIAM-Net
WHO-EM/MAL/367/E Summary report on the Intercountry meeting of national malaria programme managers from countries of HANMAT and PIAM-Net Muscat, Oman 22 24 September 2011 World Health Organization 2012
Need for Chronic Viral Hepatitis Monitoring System
Need for Chronic Viral Hepatitis Monitoring System Harry L.A. Janssen Dept. of Gastroenterology & Hepatology Erasmus University Medical Center Rotterdam The Netherlands Rotterdam November 2008 National
Methodological issues in the use of anthropometry for evaluation of nutritional status
Methodological issues in the use of anthropometry for evaluation of nutritional status Monika Blössner WHO Department of Nutrition for Health and Development Methodological issues in the use of anthropometry?
Cancer Incidence in Five Continents. Volume VIII
Cancer Incidence in Five Continents Volume VIII INTERNATIONAL AGENCY FOR RESEARCH ON CANCER The International Agency for Research on Cancer (IARC) was established in 1965 by the World Health Assembly,
HPV vaccine the global perspective
National Immunisation Conference Dublin, 25 May 2018 HPV vaccine the global perspective Robb Butler Vaccine-preventable Diseases and Immunization WHO Regional Office for Europe Presentation outline Burden
TUBERCULOSIS CONTROL WHO WESTERN PACIFIC REGION
TUBERCULOSIS CONTROL in WHO WESTERN PACIFIC REGION 2000 Report (Cases Notified in 1999) WORLD HEALTH ORGANIZATION Western Pacific Regional Office TUBERCULOSIS CONTROL IN WHO WESTERN PACIFIC REGION (Cases
Why still Polio Donato Greco ECDC polio consultant 14 April 2016
Why still Polio Donato Greco ECDC polio consultant 14 April 2016 A medical student with the last texbook on Communicable diseases! Where there is no chapter on Poliomielitis!!! What can I say o Background
Latent tuberculosis infection
Latent tuberculosis infection Updated and consolidated guidelines for programmatic management ANNEX 3 Values and preferences for the management of latent tuberculosis infection: survey of populations affected
Global Rotavirus Surveillance Network
Global Rotavirus Surveillance Network Dr. Adam L. Cohen World Health Organization 7 September 2016 1 TITLE from VIEW and SLIDE MASTER 22 September 2016 Vaccine-preventable disease surveillance Active vs.
CERVICAL CANCER A GLOBAL PERSPECTIVE
CERVICAL CANCER A GLOBAL PERSPECTIVE Andrés Poveda, MD ACOG, Fundación Instituto Valenciano de Oncología GCIG Chair Cervical Cancer Education Symposium. Mexico, Jan 2017 Gynecological Cancer Gynecological
Report by the Convention Secretariat. Purpose of the document
66 Conference of the Parties to the WHO Framework Convention on Tobacco Control Eighth session Geneva, Switzerland, 1 6 October 2018 Provisional agenda item 6.5 FCTC/COP/8/10 27 June 2018 Progress report
HPV Vaccination Global policy perspectives Vacuna VPH Perspectivas de la política de vacunación mundial
HPV Vaccination Global policy perspectives Vacuna VPH Perspectivas de la política de vacunación mundial 1 Paul Bloem EPI Team WHO IVB Geneva Outline HPV disease burden, vaccines and WHO recommendations
The Scaling-up of TB/HIV Collaborative Activities in the Asia-Pacific
Health System Strengthening and Sustaining the Response The Scaling-up of TB/HIV Collaborative Activities in the Asia-Pacific Jintana Ngamvithayapong-Yanai, Ph.D. On behalf of TB/HIV Working Group, the
Global ProhrammeUpdate?
Global ProhrammeUpdate? Polio Partners Group Meeting, Geneva, 3 December 218 On behalf of the GPEI : Michel Zaffran, Director Polio Eradication, WHO / Chairman, GPEI Strategy Committee 1 WildPoliovirus
The WHO Global Project on anti-tb drug resistance surveillance: background, objectives, achievements, challenges, next steps
The WHO Global Project on anti-tb drug resistance surveillance: background, objectives, achievements, challenges, next steps Matteo Zignol STOP TB Department World Health Organization TB surveillance and
Drug-resistant Tuberculosis
page 1/6 Scientific Facts on Drug-resistant Tuberculosis Source document: WHO (2008) Summary & Details: GreenFacts Context - Tuberculosis (TB) is an infectious disease that affects a growing number of
WORLD HEALTH ORGANIZATION. Control of neurocysticercosis
WORLD HEALTH ORGANIZATION FIFTY-SIXTH WORLD HEALTH ASSEMBLY A56/10 Provisional agenda item 14.2 6 March 2003 Control of neurocysticercosis Report by the Secretariat BACKGROUND 1. Cysticercosis of the central
The Scaling-up of TB/HIV Collaborative Activities in the Asia-Pacific
Health System Strengthening and Sustaining the Response The Scaling-up of TB/HIV Collaborative Activities in the Asia-Pacific Jintana Ngamvithayapong-Yanai, Ph.D. On behalf of TB/HIV Working Group, the
GLOBAL HIV STATISTICS
F A C T S H E E T W O R L D A I D S D A Y 2017 GLOBAL HIV STATISTICS 20.9 million people were accessing antiretroviral therapy in June 2017. 36.7 million [30.8 million 42.9 million] people globally were
Fast Facts: Ovarian Cancer
Fast Facts Fast Facts: Ovarian Cancer Christina Fotopoulou MD PhD Consultant Gynaecological Oncologist Queen Charlotte s and Chelsea Hospital London, UK Thomas J Herzog MD Professor of Obstetrics and Gynecology
Progress under GAP Pillar 2 "Increase Production Capacity" Contribution of the WHO Technology Transfer Programme. Martin Friede
Progress under GAP Pillar 2 "Increase Production Capacity" Contribution of the WHO Technology Transfer Programme Martin Friede Global influenza vaccine production capacity since 2006 Cantacuzino Romania
Prohibition of importation, manufacturing and sale of Smokeless Tobacco products.
Prohibition of importation, manufacturing and sale of Smokeless Tobacco products www.untobaccocontrol.org/kh/smokeless-tobacco/ BACKGROUND. Over the past decade, the WHO FCTC has served as a powerful tool
Key Issue #1: Why Does Development Vary Among Countries? (299)
AP Human Geography Mr. Horas Chapter 9: Development (Pages 296 329) Economic Development Before You Read: If you had to develop a scale to measure how developed (advanced ) a country is, what are three
TB epidemic and progress towards the Millennium Development Goals
Open Forum 4: Key issues in TB Drug Development, August 18, 2010, Addis Ababa, Ethiopia TB epidemic and progress towards the Millennium Development Goals Haileyesus Getahun Stop TB Department, WHO Geneva,
GLOBAL STATISTICS FACT SHEET 2015
FACT SHEET 2015 GLOBAL STATISTICS 15.8 people accessing antiretroviral therapy (June 2015) 36.9 [34.3 41.4 ] people globally were living with HIV (end 2014) 2 [1.9 2.2 ] people became newly infected with
Influenza Update N 176
Update N 176 04 January 2013 Summary Reporting of influenza activity has been irregular in the past two weeks due to the holiday season in many countries. As a result, overall virus detections have dropped
Asthma Disparities: A Global View
Asthma Disparities: A Global View Professor Innes Asher Department of Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand. mi.asher@auckland.ac.nz Invited lecture, Scientific
Vaccine Preventable Disease Surveillance: Overview. Thomas Cherian, WHO
Vaccine Preventable Disease Surveillance: Overview Thomas Cherian, WHO Global Framework on Immunization Monitoring and Surveillance (GFIMS) l An extension of the GIVS, published on December 07 - http://www.who.int/immunization/en/
Influenza Update N 162
Update N 162 22 June 2012 Summary The season is largely finished in the temperate countries of the northern hemisphere with some persistent low level transmission in eastern Europe and northern China.
Regional workshop on updating national strategic plans for the prevention of re-establishment of local malaria transmission in malaria-free countries
Summary report on the Regional workshop on updating national strategic plans for the prevention of re-establishment of local malaria transmission in malaria-free countries Casablanca, Morocco 18 20 October
Esophageal cancer Study: China Story
NCI-IARC Tumor workshop: Esophageal Squamous Cell Carcinoma Esophageal cancer Study: China Story Youlin Qiao, Shaoming Wang Dept. of Cancer Epidemiology Cancer Institute/Hospital Chinese Academy of Medical
Influenza Update N 159
Influenza Update N 159 10 May 2012 Summary The seasonal peak for influenza has passed in most countries in the temperate regions of the northern hemisphere. Different viruses have predominated in different
Oncology in Emerging Markets
Oncology in Emerging Markets W H I T E P A P E R Toll Free : (888) 987-2691 www.makrocare.com/mcsmo 1 www.makrocare.com/mcsmo C W H I T E P A P E R ancer has been the leading cause of death in economically
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. VOLUME 93 Carbon Black, Titanium Dioxide, and Talc
WORLD HEALTH ORGANIZATION INTERNATIONAL AGENCY FOR RESEARCH ON CANCER IARC Monographs on the Evaluation of Carcinogenic Risks to Humans VOLUME 93 Carbon Black, Titanium Dioxide, and Talc LYON, FRANCE 2010
Access to treatment and disease burden
Access to treatment and disease burden Robert Flisiak Department of Infectious Diseases and Hepatology Medical University in Białystok, Poland Moulin de Vernègues, 27-29 August 2015 Disclosures Advisor
Liver Cancer: Epidemiology and Health Disparities. Andrea Goldstein NP, MS, MPH Scientific Director Onyx Pharmaceuticals
Liver Cancer: Epidemiology and Health Disparities Andrea Goldstein NP, MS, MPH Scientific Director Onyx Pharmaceuticals 1. Bosch FX, et al. Gastroenterology. 2004;127(5 suppl 1):S5-S16. 2. American Cancer
XDR-TB Extensively Drug-Resistant Tuberculosis. What, Where, How and Action Steps
XDR-TB Extensively Drug-Resistant Tuberculosis What, Where, How and Action Steps The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever
Drug resistance TB in People Living with HIV: research questions and priorities.
Drug resistance TB in People Living with HIV: research questions and priorities. Haileyesus Getahun, MD, PhD. Stop TB Department World Health Organisation Geneva, Switzerland Outline of presentation Definition
Module 1: HIV epidemiology, transmission and prevention
Session 1 Module goals Module 1 Participants will be able to: -offer an insight into the epidemiological situation in the country and worldwide -present the HIV transmission modes and the broad approaches
DECLARATION ON ACCELERATION OF HIV PREVENTION EFFORTS IN THE AFRICAN REGION
DECLARATION ON ACCELERATION OF HIV PREVENTION EFFORTS IN THE AFRICAN REGION AFRO Library Cataloguing-in-Publication Data Declaration on Acceleration of HIV Prevention efforts in the African Region 1. Acquired
Maternal and Neonatal Tetanus Elimination by Yes, We Can! Global Immunization Meeting 18 th February 2009
Maternal and Neonatal Tetanus Elimination by 2012 Yes, We Can! Global Immunization Meeting 18 th February 2009 OUTLINE Can we eliminate MNT by 2012? Can MNTE contribute to MDG4? Can TT-SIAs help to deliver
DEVELOPMENT. The European Union confronts HIV/AIDS, malaria and tuberculosis. A comprehensive strategy for the new millennium EUROPEAN COMMISSION
DEVELOPMENT The European Union confronts HIV/AIDS, malaria and tuberculosis A comprehensive strategy for the new millennium EUROPEAN COMMISSION DE 121 FEB 2004 A global challenge Every minute, 11 people
Cancer Incidence and Mortality in the Kingdom of Bahrain Statistics and Trends
Cancer Incidence and Mortality in the Kingdom of Bahrain Statistics and Trends Mohammed Amin Al Awadhi, MDCM, FRCSC, FRCSI* Najat Mohammed Abulfateh, MD, Arab Board Family Medicine, MSc** Fatema Abu-Hassan,
The Child Dental Health Survey, New South Wales J. Armfield K. Roberts-Thomson J. Spencer AUSTRALIAN RESEARCH CENTRE FOR POPULATION ORAL HEALTH
The Child Dental Health Survey, New South Wales 2000 J. Armfield K. Roberts-Thomson J. Spencer AIHW Catalogue No. DEN 117 AUSTRALIAN RESEARCH CENTRE FOR POPULATION ORAL HEALTH The Australian Institute
Cervical Cancer Research in South Africa
Gynecologic Cancer InterGroup Cervix Cancer Research Network Cervical Cancer Research in South Africa Lynette Denny Department Obstetrics and Gynaecology, University of Cape Town/ Groote Schuur Hospital
Analysis of Mortality Rates of the 5 Most Frequent Primary Cancer Sites in Brazil between 1979 and 2015 for Both Sexes
Journal of Pharmacy and Pharmacology 7 (2019) 61-68 doi: 10.17265/2328-2150/2019.02.003 D DAVID PUBLISHING Analysis of Mortality Rates of the 5 Most Frequent Primary Cancer Sites in Brazil between 1979
TB Intensive Minneapolis, Minnesota September 23-26, 2008
TB Intensive Minneapolis, Minnesota September 23-26, 2008 TB in the Foreign-Born Population: Background and Demographic Overview Marge Higgins, LSW September 24, 2008 TB in the Foreign-Born Population
WHO Emergency Risk Communication
WHO Emergency Risk Communication Course Introduction Module A 1 Copyright World Health Organization 2016 All rights reserved The designations employed and the presentation of the material in this publication
WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA
WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA September 2017 Address requests about publications of the WHO Regional Office for Europe to: Publications WHO Regional Office for Europe Marmorvej
IJC International Journal of Cancer
IJC International Journal of Cancer Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 Jacques Ferlay 1, Isabelle Soerjomataram 1, Rajesh Dikshit 2, Sultan Eser
A Summary of Childhood Cancer Statistics in Australia,
What is the Australian Paediatric Cancer Registry (APCR)? The APCR is one of only a few national registries of childhood cancer in the world. It covers all Australian children aged 0-14 years old at diagnosis.
WHO Library Cataloguing-in-Publication Data. World health statistics 2011.
WORLD HEALTH STATISTICS 2011 WHO Library Cataloguing-in-Publication Data World health statistics 2011. 1.Health status indicators. 2.World health. 3.Health services - statistics. 4.Mortality. 5.Morbidity.
RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON
RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE 2018 2019 WINTER SEASON October 2018 Address requests about publications of the WHO Regional Office for Europe to: Publications WHO Regional Office for
How Is TB Transmitted? Sébastien Gagneux, PhD 20 th March, 2008
How Is TB Transmitted? Sébastien Gagneux, PhD 20 th March, 2008 Today s Outline 1) Global spread of Mtb Comparative genomics Phylogeny 2) Transmission of drug-resistant Mtb Fitness assays Molecular epidemiology
2009 Report. Tuberculosis Control. in the Western Pacific Region
2009 Report Tuberculosis Control in the Western Pacific Region Prepared by Dr Angelito Bravo was the lead author of this report. The following WHO staff from the regional and the country offices contributed
The Burden of Heart Failure in the Asia Pacific. Eugenio B. Reyes, M.D. Associate Professor, University of the Philippines, College of Medicine
The Burden of Heart Failure in the Asia Pacific Eugenio B. Reyes, M.D. Associate Professor, University of the Philippines, College of Medicine Q1. The most prevalent risk factor for heart failure in the
WHO REPORT ON THE GLOBAL TOBACCO EPIDEMIC,
WHO/NMH/PND/7.4 WHO REPORT ON THE GLOBAL TOBACCO EPIDEMIC, 207 Monitoring tobacco use and prevention policies Executive summary fresh and alive World Health Organization 207 Some rights reserved. This
THE BASICS. WHAT IS THE RED RIBBON? The Red Ribbon is the international symbol of HIV and AIDS awareness. It stands for:
THE BASICS WHAT IS THE RED RIBBON? The Red Ribbon is the international symbol of HIV and AIDS awareness. It stands for: CARE AND CONCERN It is being worn by increasing numbers of people around the world
Influenza Weekly Surveillance Bulletin
Influenza Weekly Surveillance Bulletin Northern Ireland, Weeks 46-47 (13 th November 26 th November 2017 Summary Influenza activity across Northern Ireland remains low with Flu/FLI consultations low and